Source: International Congress 2018 – Systematic reviews on the health effects of emerging tobacco products and electronic nicotine delivery systems (ENDS)
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. Kotoulas (Thessaloniki, Greece), D. Papakosta (Thessaloniki, Greece), D. Spyratos (Thessaloniki, Greece), E. Fouka (Thessaloniki, Greece), A. Markopoulou (Thessaloniki, Greece), K. Porpodis (Thessaloniki, Greece), E. Panagiotidou (Thessaloniki, Greece), E. Chatzopoulos (Thessaloniki, Greece), T. Kontakiotis (Thessaloniki, Greece), P. Argyropoulou (Thessaloniki, Greece), A. Pataka (Thessaloniki, Greece). Acute changes in PFT’s in asthma patients after the use of e-cigarette. 1723

Member's Comments

No comment yet.

Related content which might interest you: Acute effects of vaping one e-cigarette in airway inflammation of asthmatic patients Source: International Congress 2019 – Challenges in tobacco control and cessation Year: 2019 Determinants of incorrect inhalation technique in patients with asthma and COPD Source: Eur Respir J 2001; 18: Suppl. 33, 69s Year: 2001 Difference between asthma and COPD patients in adherence and non-adherence patterns to inhaler devices Source: International Congress 2015 – Is asthma always an easy disease to diagnose and manage? Year: 2015 Acute exacerbation phenotypes of asthma and COPD: impact on clinical outcomes Source: Virtual Congress 2021 – Biomarkers to phenotype asthma: prediction of exacerbations Year: 2021 Hair analysis to detect chronic inhaler drug use in asthma or COPD patients Source: International Congress 2017 – Monitoring novel biomarkers in asthma Year: 2017 The impact of smoking cessation on respiratory symptoms in patients with COPD Source: Eur Respir J 2005; 26: Suppl. 49, 391s Year: 2005 Clinical characteristics of patients with clinically-diagnosed COPD exacerbations but without concomitant airflow limitation Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD Year: 2015 Patterns of symptom change measured using the EXACT diary associated with prescription of corticosteroids or antibiotics in COPD exacerbations Source: International Congress 2015 – Notable abstracts in COPD: variety Year: 2015 Differences in inhaler misuse between patients with asthma and COPD. Source: International Congress 2018 – Pulmonary drug delivery: inhaler use, devices and technologies Year: 2018 Acute effects of tube-breathing on hyperinflation in patients with COPD Source: Eur Respir J 2006; 28: Suppl. 50, 554s Year: 2006 The impact of stepwise withdrawal of inhaled corticosteroids on exacerbations in COPD patients receiving dual bronchodilation: WISDOM study Source: International Congress 2014 – Bronchodilators for asthma and COPD Year: 2014 Severe outcomes of COVID-19 among patients with COPD and asthma Source: ERJ Open Res, 7 (1) 00594-2020; 10.1183/23120541.00594-2020 Year: 2021 Acute bronchodilator response does not predict health outcomes in patients with COPD treated with tiotropium Source: Annual Congress 2009 - Next generation bronchodilators Year: 2009 Tobacco use in relation to COPD and asthma Source: Eur Respir J 2007; 29: 438-445 Year: 2007 Sit-to-stand ability in patients hospitalised for acute exacerbation of COPD: Clinical characteristics and short-term outcomes Source: International Congress 2015 – New insights into exercise and muscle performance Year: 2015 Physical status and dependence levels in patients with COPD exacerbation Source: International Congress 2014 – Physical activity, exercise and physiotherapy in patients with COPD Year: 2014 Assessment of nicotine dependence in healthy people and patients with chronic pulmonary obstructive disease or bronchial asthma Source: Eur Respir J 2002; 20: Suppl. 38, 134s Year: 2002 The impact of stepwise withdrawal of inhaled corticosteroids on lung function in COPD patients receiving dual bronchodilation: WISDOM study Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments Year: 2014 Effect of exacerbation history and ICS use on outcomes in COPD patients from the TIOSPIR™ trial Source: International Congress 2015 – New data on established treatments for COPD Year: 2015 Changes in lung function in patients with acute COPD exacerbations: spirometry vs. forced oscillations Source: Eur Respir J 2001; 18: Suppl. 33, 149s Year: 2001